Visual Perception Difficulties After Stroke
Accuracy and Utility of the Oxford Visual Perception Screening (OxVPS), a Screening for Visual Perception Difficulties in Stroke Survivors
1 other identifier
observational
200
1 country
3
Brief Summary
The goal of this observational study is to learn how well the Oxford Visual Perception Screening (OxVPS) tool can identify stroke survivors with visual perception difficulties. The main aim is to determine the accuracy and utility of the OxVPS compared to the current gold standard assessment in stroke survivors. In other words, how well can the Oxford Visual Perception Screening tool (OxVPS) identify stroke patients with visual perception problems? Participants will completed the OxVPS and the current gold standards visual perception screening tool.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2023
CompletedFirst Submitted
Initial submission to the registry
July 31, 2023
CompletedFirst Posted
Study publicly available on registry
August 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedAugust 6, 2024
August 1, 2024
1.2 years
July 31, 2023
August 5, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Validity of OxVPS
Convergent and discriminate validity will be assessed. Convergent validity expressed as a correlation between total score on OxVPS and RPAB. Discriminate validity to be expressed as correlation between OxVPS score and scores of cognitive and sensory vision assessments. Both calculated by a non-parametric Spearman correlation and estimate a 95% confidence interval. The analysis can be completed through the cor.test function in the base package of R.
All testing completed in 2 weeks
Reliability of OxVPS
The inter-rater reliability of OxVPS will be evaluated through a Bland-Altman analysis \[26\]: we will calculate the difference in OxVPS scores between raters for each patient. Subsequently, we will plot the difference in scores as a function on the average score to evaluate a bias between the raters (mean difference) that might vary based on severity of a patient's visual perceptual problems. We will report the mean difference, standard deviation, and limits of agreement within where 95% of differences between raters fall. A t-test will indicate if the mean difference is significantly different from 0. Analyses will be performed in R with the functions from blandr package (e.g. blandr.statistics and blandr.draw) or functions from a similar package.
2 weeks
Study Arms (1)
Stroke survivors
Individuals who have survived a stroke
Interventions
Comparing a new screening tool, the Oxford visual perception screening, to the gold standard, Rivermead Perceptual Battery Assessment.
Eligibility Criteria
Stroke survivors on stroke rehabilitation units in the North East of England and Oxfordshire.
You may qualify if:
- Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage).
- Within 6 weeks of confirmed stroke.
You may not qualify if:
- Insufficient understanding of English
- Clinical concerns that patient is unable follow simple instructions.
- Clinical concerns that patient is unable to concentrate for 15 minutes.
- No capacity to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Durham Universitylead
- National Institute for Health Research, United Kingdomcollaborator
- County Durham and Darlington NHS Foundation Trustcollaborator
- University of Oxfordcollaborator
Study Sites (3)
Abingdon Community Hospital
Abingdon, OX14 1AG, United Kingdom
Bishop Auckland Hospital
Bishop Auckland, DL14 6AD, United Kingdom
Queen Elizabeth Hospital
Gateshead, NE9 6SX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen Vancleef, PhD
Durham University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoc researcher
Study Record Dates
First Submitted
July 31, 2023
First Posted
August 8, 2023
Study Start
June 20, 2023
Primary Completion
August 31, 2024
Study Completion
February 28, 2026
Last Updated
August 6, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share